Concepedia
Statistics
Publications
12
Citations
322
H-Index
10
Active since
2012
Affiliations
GlaxoSmithKline (United States)(Current)
GlaxoSmithKline (United Kingdom)
Research Triangle Park Foundation
GlaxoSmithKline (India)
GlaxoSmithKline (France)
Kelly M. Mahar is an author at GlaxoSmithKline (United States) specializing in medicine, physiology, and metabolic syndrome.
Top concepts
MedicinePhysiologyMetabolic SyndromeHealthDiabetesEducationImmunologyPharmacologyHyperglycemiaAnesthesiology
Publications per year
2012–2021
Gastric pH and Gastric Residence Time in Fasted and Fed Conscious Beagle Dogs using the Bravo® pH System
Kelly M. Mahar, Samm Portelli, Robert W. Coatney et al. · Journal of Pharmaceutical Sciences · 2012 · 60 citations
Animal Physiology, Veterinary Physiology, Gastric Ph +11
Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease
Eric J. Olson, Laura A. Demopoulos, Thomas Haws et al. · Vascular Medicine · 2014 · 47 citations
Safety and Efficacy of Epelsiban in the Treatment of Men with Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study
Rajesh Shinghal, Allison Barnes, Kelly M. Mahar et al. · The Journal of Sexual Medicine · 2013 · 45 citations
A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis
Christine K. Bailey, S Caltabiano, Alexander R. Cobitz et al. · BMC Nephrology · 2019 · 34 citations · Full text
<scp>GSK256073</scp> , a selective agonist of G‐protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus
Robert L. Dobbins, Shawn Patrick Shearn, Robert Byerly et al. · Diabetes Obesity and Metabolism · 2013 · 33 citations
1–5 of 12